FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100858 [Registered on: 12/01/2026] Trial Registered Prospectively
Last Modified On: 11/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Study between Tamsulosin and in Combination with Deflazacort in Distal Ureteric Calculus less than 10mm 
Scientific Title of Study   Tamsulosin alone and in Combination with Deflazacort for Medical Expulsion therapy of Distal Ureteric Calculus less than 10mm: A Randomized Controlled Study 
Trial Acronym  MET 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Pusarla Subash Chandra 
Designation  Senior Resident 
Affiliation  MBBS, M.S(General surgery) 
Address  Room no 14, OPD Building, Department of Urology and Renal Transplant, KMC MANIPAL

Udupi
KARNATAKA
576104
India 
Phone  8978252790  
Fax    
Email  psubashchandra@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Sunil Pillai Bhaskarsa 
Designation  Professor & HOD 
Affiliation  MBBS, MS(Gen Surgery), MRCS(Glasgow), Mch(Urology), FRCS(Urology)(Glasgow) 
Address  Room no 14, OPD Building, Department of Urology and Renal Transplant, KMC MANIPAL

Udupi
KARNATAKA
576104
India 
Phone  9731855209  
Fax    
Email  sunil.pillai@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Pusarla Subash Chandra 
Designation  Senior Resident 
Affiliation  MBBS, M.S(General surgery) 
Address  Room no 14, OPD Building, Department of Urology and Renal Transplant, KMC MANIPAL

Udupi
KARNATAKA
576104
India 
Phone  8978252790  
Fax    
Email  psubashchandra@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Pusarla Subash Chandra 
Address  Room No 14 OPD Building Department of Urology and Renal Transplant KMC MANIPAL karnataka India 576104 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pusarla Subash Chandra  KMC MANIPAL  Room no 14, OPD Building, Department of Urology and Renal Transplant, Kasturba medical college, MANIPAL. Udupi(Dt). Karnataka. India
Udupi
KARNATAKA 
8978252790

psubashchandra@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N201||Calculus of ureter,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Tamsulosin  0.4mg per oral for 3 weeks 
Intervention  Tamsulosin + Deflazacort  0.4mg + 30mg per oral for 3 weeks 
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1) All patients who report to emergency/ Urology OPD with ureteric calculi 10 mm or less in
size willing to give consent for the study 
 
ExclusionCriteria 
Details  1) Patient with urinary tract infection (based on urine routine analysis and fever),2) Uncontrolled pain,3) Impaired kidney function (Serum creatinine greater than 1.4 mg/dl), 4) Solitary kidney,5) Diabetic patients(HbA1c greater than 7%) 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To assess stone expulsion rates on treatment with alpha blockers (Tamsulosin) and in combination
with corticosteroids (Tamsulosin + Deflazacort) in patients diagnosed with distal ureteric calculus less than or equal to 10mm 
3 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To assess stone expulsion based on size of stone (less than 5mm, 5-10 mm)  3 weeks 
Quantification of Analgesics used (using analgesic quantification score)  3 weeks 
Average time of stone clearance (NCCT KUB on h/o passage of stone or at 03 weeks whichever is
earlier). 
3 weeks  
 
Target Sample Size   Total Sample Size="162"
Sample Size from India="162" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   22/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a randomized controlled study comparing Tamsulosin alone and in combination with Deflazacort for medical expulsion therapy of Distal Ureteric Calculus less than or equal to 10mm for 2 years that will be conducted at Kasturba Hospital Manipal. The primary outcome will be  to assess stone expulsion rate at 3 weeks. The secondary outcomes will be stone expulsion rate based on size, quantification of analgesics used and average time of stone clearance. 
Close